• M&A and Investment Due Diligence for Venture Capital, Private Equity, and Corporate Business Development;• Strategic and Tactical Market Access, Health Economic, and Clinical Value Positioning and Messaging;• Reimbursement Landscape Assessments (e.g., Coding, Coverage & Payment);• Regulatory/Clinical Landscape Assessments (e.g., clinical trial/study/registry design, FDA submissions, Breakthrough Designation, Data Analysis);• Medicare Alternative Payment Pathways (i.e., Inpatient NTAP, Outpatient Transitional Pass-Through (TPT) Status, New Technology APC);• Navigating Value Analysis Committees, Pricing, GPO/IDN Contracting, and Strategic and Tactical Competitive Selling/Positioning.

• Volunteer presenter/mentor to the ZeroTo510 medical device accelerator’s entrepreneur CEOs on strategies and tactics on market access opportunities and challenges, coding, coverage and payment, premium pricing, value messaging, and value differentiation against competitive technologies and/or standards of care.

• Volunteer mentor to Israeli medical device company CEOs to help them craft their clinical data, health economic, and US market access strategies, with emphasis on payer/purchaser value differentiation against competitive technologies and standards of care;• Featured speaker presenting and educating the 8400 Network HealthTech CEO and Executive Management members on US market access realities, challenges and opportunities for bringing new, innovative, and/or disruptive technologies to market.

• Member of Executive Management Team reporting directly to the CEO;• Responsible for a $1M budget to lead all global corporate strategies and tactics for obtaining, improving and protecting reimbursement, purchaser and payer value messaging, and premium pricing across all global commercial markets;• Define and execute health economic research, data, and cost-effectiveness and budgetary impact publication efforts to support positive US payer coverage and for global health technology assessments;• Drive market access and reimbursement throughout the full product life cycle inclusive of collaboration with physician and facility customers, engagement of external stakeholders and organizations (e.g. specialty societies), and active advocacy with governmental and commercial payers;• Implement strategic and tactical launch plans for securing coding and coverage, and available payment mechanism opportunities, and coordinate with Sales for the premium pricing opportunity using innovative contracting models;• Create customizable health economic value tools, such as cost effectiveness and budget impact models to demonstrate the clinical and economic value to facility purchasers, technology assessment bodies, and payers;• Develop, launch and maintain country-specific reimbursement and market access services, resources and collateral, including patient access program, reimbursement hotline, clinical and economic value dossiers, coding guides, reimbursement kits, contracting and pricing, and Sales, Marketing, and Field Reimbursement support;• Participate in business development, VC and Investor presentations, and due diligence activities.

• Elevated to lead the global, corporate strategic and tactical responsibilities for reimbursement, health economics and market access following the March 1, 2013 acquisition of BioMimetic Therapeutics by Wright Medical Technology;• Responsible for a $750,000 annual budget, one direct US report, one shared Australia report, and multiple contracted reimbursement professionals;• Developed health economic initiatives, value messaging, and payer coverage strategies to obtain, improve and protect reimbursement and premium pricing opportunity for Wright Medical’s products and therapies across global markets;• Drove market access and reimbursement initiatives during the product life cycle management process, across all global markets, including reimbursement opportunity, maximum sustainable pricing, influencing market uptake, and taking market share from competitors;• Developed and launched health economic models and value selling tools to support Sales, Contracting, Pricing and Marketing including budget impact models, payer-mix reimbursement modeling, value dossiers and publications;• Collaborated with corporate leadership, US business teams, and OUS leadership to proactively identify health economic needs, market trends, and strategic and tactical initiatives for sustaining premium pricing;• Aligned with the Clinical department on health economic endpoints in clinical studies, and data mining activities, to create fact-based clinical and economic value messaging for Wright Medical’s products and therapies;• Corporate compliance and legal responsibilities as a voting member of Wright’s Arrangements Review Committee (physician engagement and contracting) and Royalty Review Committee (physician developer royalty determination);• Participate in business development and M&A diligence activities.

• Competitive positioning of BioMimetic Therapeutics’ products to standards of care and competitive technologies, inclusive of coverage, coding, payment, and health economic/budgetary impact value differentiation: - Led all health economic publication initiatives to influence market uptake and patient access to treatment;• Developed the global strategic and tactical plans, with responsibility for a $300,000 annual budget;• Drove the inclusion of health economic endpoints into clinical study design to build the short- and long-term clinical and economic value proposition for patients, providers, payers, and OUS Ministries of Health/HTAs;• Created country-specific cost effectiveness and budgetary impact models for informing and influencing hospital technology evaluation committees, payer coverage policy decision makers, and health technology assessment bodies:• Executed global reimbursement, and procedural code development/refinement initiatives, including country-specific procedural coding applications and evidence/value dossiers;• Collaborated with Sales and Marketing to develop and implement strategic and tactical plans for premium pricing, customer segmentation, product uptake, and market adoption, and market share expansion;• Established reimbursement tools and resources for patients, physicians, and facility purchasers;• Represented BioMimetic Therapeutics at domestic and international Society meetings and Congresses.

• Established Zimmer’s continuum of Health Economics and Reimbursement Customer Programs offerings: - Reimbursement Hotline; - Customer Health Ecomomics Educational Webinar program on orthopaedic and spine coding; - Coding Guides and product-specific Reimbursement Kits; - Health Economics and Reimbursement website; - Sales education;• Integrated health economic and reimbursement landscape assessments and strategic and tactical implementation plans into new product development initiatives.

• Chief Lobbyist and Health Policy Officer for the Michigan Nurses Association directing and leading all Legislative, Governmental Affairs, and Health Policy activities of the Association;• Established and led the annual legislative and policy platforms and priorities for the Association;• Staff leadership to the MNA-PAC Board of Trustees: - Annual $100,000 budget for strategic political campaign donations; - Liaison to the American Nurses Association Government Affairs Committee and the ANA-PAC;• Planned, directed, and lead the annual Nurses Impact Advocacy Day at the Capitol averaging over 1,500 Registered Nurses and nursing student attendees.

· Taught Principles of Health Care Administration (Parts I & II) – Graduate courses PS 560 and PS 561· Taught Legal Aspects of Health Care Administration (Parts I & II) – Graduate courses PS 670 and PS 671

• Directed and advanced the Association’s legislative, regulatory, and health care policy initiatives in the areas of: - Managed care and commercial insurance; - BCBSM, HMO and insurance regulation, payer solvency, and health plan licensure; - Provider billing and Payer reimbursement issues; - Integrated health care delivery system issues;• Co-Chairperson of the Benefit Administration Committee per Michigan’s Participating Hospital Agreement (Michigan Public Act 350 of 1980; governing administrative, policy and operational dealings between Michigan's hospitals and Blue Cross Blue Shield of Michigan): - Identified and corrected a claims adjudication process error resulting in BCBSM paying $36 million in previously unresolved and unpaid hospital claims;• Liaison to the CMS Region V office in Chicago;• Administrator of the Michigan State Uniform Billing Committee governing the use of the CMS 1450 (UB-02) inpatient/outpatient hospital claim form;• Registered Michigan Lobbyist Agent.

· Taught Managed Care Services – Undergraduate course HCM 442

• Responsible for 400 benefit plans spanning commercial, self-funded, and governmental insurance offerings.